Literature DB >> 2064386

Orphan products: origins, progress, and prospects.

M E Haffner1.   

Abstract

Mesh：

Year:  1991        PMID： 2064386     DOI： 10.1146/annurev.pa.31.040191.003131

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  2 in total

Review 1.  The economics of orphan drug policy in the US. Can the legislation be improved?

Authors:  J W Peabody; A Ruby; P Cannon
Journal:  Pharmacoeconomics       Date:  1995-11       Impact factor: 4.981

2.  Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson disease.

Authors:  David F Moore; Markus Ries; Evelyn L Forget; Raphael Schiffmann
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.